SecBot SecBot
Institutional Cluster

VERA

Vera Therapeutics, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed5mo ago
Institutional cluster: 7 buyers, 2 sellers (bullish)
Actionable Insight ▲ Bullish

The concentration of new and doubled positions from high-conviction active funds (Point72, Citadel, Two Sigma) signals strong institutional belief in near-term catalysts. Monitor for atacicept Phase 3 data or regulatory updates. The Morgan Stanley exit is a cautionary signal but appears idiosyncratic given the broad buying.

DirectionBullish
Confidencemedium
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$33.65
T+0 close · Jun 11, 2026 · via day close
Latest settled
+6.66%
T+60 · $35.89
Vs SPY
+2.26%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 11 $33.65entry
  2. T+1 · 5mo ago +1.81%α +1.27% · $34.26
  3. T+5 · 5mo ago +4.04%α +3.61% · $35.01
  4. T+20 · 4mo ago +26.15%α +24.26% · $42.45
  5. T+60 · 2mo ago +6.66%α +2.26% · $35.89

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Seven institutional investors accumulated $115.7M in VERA during Q3 2025, led by Point72's new $37M position and Citadel's doubling to $46.9M, while Morgan Stanley nearly exited its $52.7M stake. The cluster is dominated by active quant and asset-manager buyers, suggesting a shared thesis around Vera's pipeline catalysts (likely atacicept in IgA nephropathy) outweighing the risk-off signal from Morgan Stanley's exit.

Key Financial Metrics

Direction
accumulating
Buy Value
$115.7M
Sell Value
$56.1M
Net Flow
$44.0M

Institutional Positions

Net institutional flow: $44.0M

▲ Buyers (7)

InstitutionActionChangePosition ValueValue Δ
Point72NEWNot reported$37.0M$37.0M
CitadelDOUBLED+187%$46.9M$33.7M
Dimensional Fund AdvisorsDOUBLED+134.5%$10.5M$6.9M
NuveenDOUBLED+191.5%$9.2M$6.7M
Two SigmaADD+32.9%$5.0M$1.9M
UBSADD+57.5%$4.7M$2.3M
Wells FargoDOUBLED+140%$2.4M$1.6M

▼ Sellers (2)

InstitutionActionChangePrev ValueValue Δ
Morgan StanleyNEAR_EXIT-87.7%$52.7M-$44.8M
Ubs Am, A Distinct Business UnTRIM-46.3%$3.6M-$1.2M

Key Facts

  • 7 buyers accumulated $90.0M net; 2 sellers reduced by $46.0M
  • Point72 initiated a new $37.0M position (1.27M shares)
  • Citadel doubled its stake to $46.9M (+$33.7M)
  • Morgan Stanley cut 87.7% of its position, exiting $44.8M
  • Active managers (Point72, Citadel, Two Sigma) drove 80% of buying value
  • Passive rebalancing by Wells Fargo and UBS added modest $3.9M combined

Financial Impact

Net institutional buying of $44.0M (7 buyers added $90.0M, 2 sellers removed $46.0M) represents ~1.9% of VERA's $2.3B market cap

institutional ownershipfloatshare price

Risk Factors

  • 13F data is 45+ days stale; positions may have been unwound
  • Morgan Stanley's near-exit could reflect material non-public concerns
  • Biotech binary catalyst risk, any pipeline setback would reverse the thesis

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-VERA-2025-Q3

Track record

25 reports on VERA

Performance horizon

12 of 13 bullish or bearish reports moved the stock their way by T+5. Best: +36.47% at T+20 after the Jun 2, 2026 report. 13 of 13 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $27.55 settles Nov 23
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
  4. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $30.03 settles Nov 17
  5. Nov 5, 202611d ago 8-K Bullish 6/10 No price data
  6. Nov 5, 202611d ago Press Release Bullish 6/10 Entry $29.79 to $28.10 ▼ −5.66% −8.25% vs SPY
  7. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $31.97 to $30.48 ▼ −4.66% −3.75% vs SPY
  8. Oct 22, 202625d ago Press Release Bullish 8/10 Entry $29.05 to $30.53 ▲ +5.09% +4.39% vs SPY
  9. Sep 15, 20268w ago 8-K Bullish 8/10 Entry $33.67 to $34.00 ▲ +0.98% +0.16% vs SPY
  10. Aug 10, 202614w ago 8-K Neutral 5/10 No price data
Showing 10 of 25

US Market Status

Market Closed · Opens Wed (9h 45m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026